Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy.

MLA

Vella, Veronica, et al. “Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-Inflammation and Potential in Cancer Therapy.” Endocrine Reviews, vol. 44, no. 4, July 2023, pp. 693–723. EBSCOhost, https://doi.org/10.1210/endrev/bnad005.

APA

Vella, V., Lappano, R., Bonavita, E., Maggiolini, M., Clarke, R. B., Belfiore, A., & De Francesco, E. M. (2023). Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy. Endocrine Reviews, 44(4), 693–723. https://doi.org/10.1210/endrev/bnad005

Chicago

Vella, Veronica, Rosamaria Lappano, Eduardo Bonavita, Marcello Maggiolini, Robert Bryan Clarke, Antonino Belfiore, and Ernestina Marianna De Francesco. 2023. “Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-Inflammation and Potential in Cancer Therapy.” Endocrine Reviews 44 (4): 693–723. doi:10.1210/endrev/bnad005.